- Home
- ONCH vs IMRX Comparison
ONCH vs IMRX Comparison
Compare ONCH & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCH
- IMRX
- Stock Information
- Founded
- ONCH 2024
- IMRX 2008
- Country
- ONCH United States
- IMRX United States
- Employees
- ONCH N/A
- IMRX N/A
- Industry
- ONCH
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- ONCH
- IMRX Health Care
- Exchange
- ONCH Nasdaq
- IMRX Nasdaq
- Market Cap
- ONCH 221.4M
- IMRX 232.9M
- IPO Year
- ONCH 2025
- IMRX 2021
- Fundamental
- Price
- ONCH $10.38
- IMRX $6.21
- Analyst Decision
- ONCH
- IMRX Strong Buy
- Analyst Count
- ONCH 0
- IMRX 4
- Target Price
- ONCH N/A
- IMRX $17.75
- AVG Volume (30 Days)
- ONCH 31.3K
- IMRX 3.5M
- Earning Date
- ONCH 01-01-0001
- IMRX 11-12-2025
- Dividend Yield
- ONCH N/A
- IMRX N/A
- EPS Growth
- ONCH N/A
- IMRX N/A
- EPS
- ONCH N/A
- IMRX N/A
- Revenue
- ONCH N/A
- IMRX N/A
- Revenue This Year
- ONCH N/A
- IMRX N/A
- Revenue Next Year
- ONCH N/A
- IMRX N/A
- P/E Ratio
- ONCH N/A
- IMRX N/A
- Revenue Growth
- ONCH N/A
- IMRX N/A
- 52 Week Low
- ONCH $10.18
- IMRX $1.10
- 52 Week High
- ONCH $10.63
- IMRX $10.08
- Technical
- Relative Strength Index (RSI)
- ONCH N/A
- IMRX 47.03
- Support Level
- ONCH N/A
- IMRX $6.02
- Resistance Level
- ONCH N/A
- IMRX $9.54
- Average True Range (ATR)
- ONCH 0.00
- IMRX 0.96
- MACD
- ONCH 0.00
- IMRX -0.36
- Stochastic Oscillator
- ONCH 0.00
- IMRX 4.68
About ONCH 1RT Acquisition Corp. Class A Ordinary Share
1RT Acquisition Corp is a blank check company.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.